Abstract: A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A transdermal colloidal dispersion delivery system for use in the treatment of HIV-1 infection further comprises an emulsion of resolubilized, concentrated mammalian liver extract.

Abstract: Compositions for the treatment of fungal nail disease (onychomycosis), including camphor, menthol, eucalyptus and thymol are described. The ingredients are natural and very effective in treating the nail fungus.

Abstract: The invention relates to a process for the isolation of compound scopoletin which is used as nitric oxide synthesis inhibitor from Artemisia annua and other plant families, said process comprising extraction of dried powdered material of different plant parts with an aqueous acetonitrite solvent in the ratio of 1:5 for 6 to 8 hrs., concentration of the extracted solvent upto 30% of its original extract under vacuum, partitioning the concentrated extract with halogenated solvent to transfer scopoletin in the non-polar halogenated solvent, drying halogenated solvent over anhydrous sodium sulphate and evaporating the solvent, crystallizing the residues in methanol and filtering the crystals, concentrating the filtrate and chromatographed on silica gel, eluting scopoletin in chloroform methanol mixture; and crystallization of the fractions containing the scopoletin to get the pure scopoletin compound.

Abstract: A stabilized aqueous enzyme concentrate composition which comprises: a) 1000 to 1800 units/ml of lactoperoxidase; b) 1500 to 2750 units/ml of glucose oxidase; c) 10 to 20% w/v of an alkali metal halide salt; and d) a chelating buffering agent present in an amount such that the pH of the composition is in the range of 5.5 to 6.5.

Abstract: A method of increasing the concentration of caffeic acid derivatives, such as cichoric acid, and the concentration of alkylamides, such as tetraene alkylamides, in Echinacea plant postharvest; and a composition, having increased amounts of these phytochemicals per gram of plant material. The method includes the following steps: (1) harvesting a plant having caffeic acid derivatives and alkylamides; (2) separating the plant into fragments; and (3) storing the separated fragments in refrigerated conditions at a controlled relative humidity which prevents wilting and microbial decay. The raw plant material obtained from this process can be used alone or in combination with other nutrients in a medicine or dietary supplement.

Abstract: This invention relates to the topical treatment of keloids, hypertrophic scars and burn scars by the use of a selected protein kinase c inhibitor and an effective penetrating agent selected from lecithin organogel or poloxamer 407 lecithin organogel. The protein kinase c inhibitors may be selected from sphingosine, sphinganine, phytosphingosine, N-Acetylsphingosine, N-Hexanoylsphingosine, N-Octanoylsphingosine, curcumin, tetrahydrocurcumin, curcuminoids or apigenin.

Abstract: Formulations containing spores of non-toxigenic strains of fungi are useful biocontrol agents for preventing toxin contamination in agricultural commodities, especially those for human and animal consumption such as peanuts, corn and cotton. These formulations include spores mixed with vegetable oil and applied to dry grain. Diatomaceous earth is added to the spore, oil and grain mixture to form a flowable formulation.

Abstract: The invention concerns a pharmaceutical composition containing, as active principle, at least one NO syntase inhibiting substance and at least one oxygen reactive form trapping substance, optionally with a pharmaceutically acceptable support. The invention also concerns a product containing at least one NO syntase inhibiting substance and at least one oxygen reactive form trapping substance as combined product of these active principles in separate form.

Abstract: The invention relates to isolates of Streptomyces orientalis Y31014 and Streptomyces melanogenes Y31042-1 can be effectively control whiteflies. The invention also concerns a novel biopesticide and its use to control pests.

Abstract: The invention relates to isolates of Streptomyces orientalis Y31014 and Streptomyces melanogenes Y31042-1 can be effectively control whiteflies. The invention also concerns a novel biopesticide and its use to control pests.

Abstract: The subject invention relates to fibrin sealants. More specifically, the subject invention relates to the use of a fibrin sealant wherein a composition comprising fibrin monomer or a composition comprising noncrosslinked fibrin is utilized as a component of the fibrin sealant.

Abstract: Compositions having hypoglycemic and/or hypolipidemic activity are isolated from natural sources including yeast and Saltbush (Atriplex halmus). In addition, synthetic chromium complexes were prepared. Compositions possessing hypoglycemic and/or hypolipidemic activity with or without chromium containing natural and synthetic compounds are formulated for use in animals and humans. Methods for use of the compositions alone, or in combination with antioxidant agents, for regulating glucose and lipid levels in diabetes, cardiovascular diseases, inflammatory and cell proliferative diseases and in skin conditions, are presented.

Abstract: References, i.e., solutions of known concentration for use as controls, calibrators, or standards, for assays of carbohydrate-deficient transferring in bodily fluids are obtained from units of bodily fluids from normal healthy individuals by digesting the transferring in these units with exogenous neuraminidase to achieve concentrated CDT solutions, which are then added in preselected proportions to a base matrix to achieve target concentrations.

Abstract: The present invention relates to a method for preparation of plant extract powder and oral compositions containing plant extract powder prepared by the same. More particularly, the present invention could provide a method for preparation of plant extract powder comprising the steps of (a) loading a plant extract having activities of prevention of and treatment for periodontal diseases or tooth decay into a porous powder carrier; (b) coating said carrier's surface with a water-insoluble coating agent and oral compositions containing plant extract powder prepared by the above described method which have an excellent periodontal diseases preventing effect and tooth decay preventing effect.

Abstract: The present invention is directed to a method for determining the level of oxidized glutathione, or the ratio of reduced glutathione to oxidized glutathione, in a biological sample utilizing the thiol scavenging reagent 1-methyl-2-vinylpyridinium trifluoromethanesulfonate or another salt thereof at a level which rapidly scavenges reduced glutathione but does not interfere with the measurement of oxidized glutathione.

Abstract: The invention relates to a simplified process for the extraction of heparin from animal mucosa tissue. The method consists of an enzymatic hydrolysis step of the raw material at ambient temperature, followed by hydrolysis for up to 6 hours at a temperature of 50-75° C. Raise in temperature is obtained by easy means. The digestion mixture can be further incubated while cooling down to ambient temperature. Heparin is recovered from anion exchanger present in the protein hydrolysate.

Abstract: The present invention relates to a process for extraction of curcuminoids from Curcuma species, which comprises the steps of contacting the rhizome of Curcuma species with an aqueous hydrotrope solution at a temperature in the range of 0-100° C. for extraction of curcuminoids, separating the solution obtained from the solid residue, and recovering the curcuminoids from the solution by known methods.

Abstract: A liquid health supplement comprising: (i) from about 1% to about 99% of a combination of at least 150 different carotenoid compounds with structures having chemical formula I: wherein each R group is the same or different and is selected from the group consisting of hydrogen, straight chain or branched C1-8 alkyl, straight chain or branched C1-8 alkenyl, straight chain or branched C1-8 alkynyl, hydroxy, straight chain or branched C1-8 alkoxy, keto, carboxyl, cyano, nitro amino, amide, ester, ether, halogen, substituted acyclic, substituted or unsubstituted cyclic, aromatic and heteroaromatic; and, (ii) an oil in an amount sufficient to mask the smell of the carotenoid compounds selected from the group of natural plant oils obtained from plant matter.

Abstract: The present invention provides a method for the prevention and treatment of chronic venous insufficiency. Specifically, the present invention provides a method for the prevention and treatment of varicose veins, particularly hemorrhoids by application of an effective amount of an isoquinoline alkaloid. Included in this invention is an improved method for isolating and purifying alkaloids, particularly isoquinoline alkaloids from plants.

Abstract: A procedure for the production of tablets and capsules of natural substances of vegetable origin, in which dry extracts and micronized powders of one or more medicinal herbs are mixed in appropriate proportions. The mixture is then subjected to granulation by means of steam at atmospheric pressure, dry air is introduced for the elimination of the steam and to start the drying process, through which the granules produced by the steam are consolidated, before they are put into the machine that will make the tablets and capsules, without the use of excipient or adjuvant substances.